Generic Pharmaceuticals Company Investment Opportunity in Manila, Philippines
Looking for investors for a fast-growing pharmaceutical development and distribution company in Manila, Philippines.
This transaction has concluded.
| Established | 10-20 year(s) |
| Employees | 100 - 500 |
| Legal Entity | Private Limited Company |
| Reported Sales | USD 8 million |
| Run Rate Sales | USD 12 million |
| EBITDA Margin | 30 % |
| Industries | Generic Pharmaceuticals |
| Locations | Manila |
| Local Time | 4:17 AM Asia / Kuala Lumpur |
| Listed By | Advisor / Business Broker |
| Status | Active |
Partial Stake Sale
USD
20 million
for
30.0%
stake
(Native Currency: USD 20,000,000)
Reason: To expand our market globally by developing more products and secure over 300 distribution channels ...
View More
Includes physical assets worth
USD
7 million
Interested to connect with advisors
Business Overview
- We are one of the largest and fastest growing pharmaceutical companies in Manila, Philippines, operating since 2009.
- The business comprises three of the world's leading ethical products: Norepin, Ifimol and Dobulex.
- We make sure we deliver quality and cost-effective medicines.
- Company supplies critical illness drugs to 90% of hospitals in Philippines.
- Working with 9 leading brands that are market leaders. All products have met strict standards for testing and assessment.
- We are currently distributing 10 patented products to more than 100 hospitals in the Philippines.
- Our production capacity is worth USD 8 million per annum.
- Sterling growth for the past 10 years and ranked 40th among All Ethical National Pharmaceutical Companies.
- We continue to partner with companies that are considered institutions in their own countries such as Smith, Kalbe Farma, Ambica Solutions, Farmatek.
- Our sales increased this year because we are now selling our products to both hospitals and pharmacies.
- Our assets include land, factory, warehouses, machinery, raw materials and stock.
- Promoter has more than 10 years of experience in this business.
- The business comprises three of the world's leading ethical products: Norepin, Ifimol and Dobulex.
- We make sure we deliver quality and cost-effective medicines.
- Company supplies critical illness drugs to 90% of hospitals in Philippines.
- Working with 9 leading brands that are market leaders. All products have met strict standards for testing and assessment.
- We are currently distributing 10 patented products to more than 100 hospitals in the Philippines.
- Our production capacity is worth USD 8 million per annum.
- Sterling growth for the past 10 years and ranked 40th among All Ethical National Pharmaceutical Companies.
- We continue to partner with companies that are considered institutions in their own countries such as Smith, Kalbe Farma, Ambica Solutions, Farmatek.
- Our sales increased this year because we are now selling our products to both hospitals and pharmacies.
- Our assets include land, factory, warehouses, machinery, raw materials and stock.
- Promoter has more than 10 years of experience in this business.
Products & Services Overview
Critical care products, Anesthesia products, Anti-bacterial products.
Facilities Overview
Company owned office, factory and 2 warehouse facilities with a total area of 1090 sq mt. The warehouse has passed the procurement inspection of the Joint Commission International (JCI). The warehouse is complete with fire alarm, door access, CCTV, standby 35KBA back-up emergency power, internet, mobile digital hygrometer, mobile stock picker, pallet truck, steel rock and delivery vans in Manila and in provincial areas.
Capitalization Overview
Not Disclosed
Recent Activity
-
Earlier than 15 daysFounder And CEO, Investment Company, Singapore, Corporate Investor / Buyer connected with the Business
-
Earlier than 15 daysIndependent Advisor, Chennai, Financial Consultant connected with the Business
-
Earlier than 15 daysCEO, Milan, Financial Consultant connected with the Business
Tags:
Generic Pharmaceuticals Company Investment Opportunity in Manila, Philippines
·Invest in Generic Pharmaceuticals Company in Manila, Philippines
·Generic Pharmaceuticals Company Investment Opportunity
·Investment Opportunity in Manila, Philippines
·Invest in Generic Pharmaceuticals Company
·Invest in Manila, Philippines
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
